• Publications
  • Influence
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data
BACKGROUND Atrial fibrillation is the most common supraventricular arrhythmia in patients with acute myocardial infarction. Recent advances in pharmacological treatment of myocardial infarction mayExpand
  • 256
  • 14
  • PDF
Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.
In a previous three-month study of Meriva, a proprietary curcumin-phosphatidylcholine phytosome complex, decreased joint pain and improvement in joint function were observed in 50 osteoarthritis (OA)Expand
  • 186
  • 14
  • PDF
Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis.
AIM A proprietary complex of curcumin with soy phosphatidylcholine (Meriva®, Indena SpA) was evaluated in a registry study to define its efficacy in 50 patients with osteoarthritis (OA) at dosagesExpand
  • 111
  • 7
  • PDF
Comparison of Pycnogenol® and Daflon® in Treating Chronic Venous Insufficiency: A Prospective, Controlled Study
The aim of this study was to investigate the clinical efficacy of oral Pycnogenol® (Horphag Research Ltd., UK) in patients with severe chronic venous insufficiency (CVI) in comparison to theExpand
  • 45
  • 4
  • PDF
Venoruton® vs Daflon®: Evaluation of Effects on Quality of Life in Chronic Venous Insufficiency
The aim of this independent study was to investigate differences in efficacy between oxerutins (Venoruton) and 500 mg micronized diosmin + hesperidin (D+H) (Daflon) in patients with chronic venousExpand
  • 43
  • 4
Meriva®+Glucosamine versus Condroitin+Glucosamine in patients with knee osteoarthritis: an observational study.
OBJECTIVE Osteoarthritis (OA) is a major cause of physical disability and impaired quality of life. Non-steroidal anti-inflammatory drugs are the most used treatment for OA, but they are frequentlyExpand
  • 26
  • 4
  • PDF
Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study.
The aim of this study was to evaluate the clinical efficacy of standardized French maritime pine bark extract Pycnogenol in patients with severe chronic venous insufficiency (CVI). 98 subjects withExpand
  • 35
  • 3
Improvement of Diabetic Microangiopathy With Pycnogenol®: A Prospective, Controlled Study
The aim of this study was to investigate the clinical efficacy of oral Pycnogenol® (Horphag Research Ltd, United Kingdom) in patients with diabetic microangiopathy. Patients without a history ofExpand
  • 44
  • 3
Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.
BACKGROUND The aim of the study was the evaluation of the efficacy of Pycnogenol® in peri-menopausal women in controlling homocysteine and C-reactive protein (CRP) levels, borderline cardiovascularExpand
  • 7
  • 3
Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy.
BACKGROUND In the present study, the improvement of diabetic microangiopathy and retinopathy was evaluated in 38 diabetic patients treated with a novel curcumin phospholipids delivery form (Meriva®).Expand
  • 56
  • 2
  • PDF